Research Progress on Molecular Diagnosis and Individualized Treatment for Malignant Lymphoma / 肿瘤防治研究
Cancer Research on Prevention and Treatment
; (12): 1165-1173, 2023.
Article
Dans Zh
| WPRIM
| ID: wpr-1003795
Responsable en Bibliothèque :
WPRO
ABSTRACT
Lymphoma refers to a group of heterogeneous malignancies originating from the reticuloendothelial and lymphatic systems. The clinical manifestations, treatment strategies, and disease outcomes of different types of lymphoma considerably vary. Recent developments in high-throughput sequencing technologies have enhanced understanding of the pathogenesis and molecular stratification of lymphoma. In the era of new drugs, precise stratification and targeted drug selection can not only improve the prognosis of patients with lymphoma but also reduce the toxic side effects of traditional chemotherapy, ultimately achieving the accurate diagnosis and individualized treatment of tumors. This article reviews the research progress of molecular diagnosis and individualized treatment of different lymphoma subtypes and lymphoma-related research in important meetings such as ASCO, EHA, and ICML in 2023.
Texte intégral:
1
Indice:
WPRIM
langue:
Zh
Texte intégral:
Cancer Research on Prevention and Treatment
Année:
2023
Type:
Article